Pancreatitis
Conditions
Brief summary
This study is an ancillary of APPRENTICE. This will be the international based study.
Detailed description
This study is an ancillary of APPRENTICE. This will be the international based study. The initial study design with discussions about the different variables to be included into our prospective database started during 2014 PancreasFest held in Pittsburgh, PA in late July 2014 under the sponsorship of Collaborative Alliance for Pancreatic Education and Research (CAPER). Following this, a datasheet with variables was created, distributed through the initial participants, and further suggestions and edits were made. We now plan to move ahead with a web based seminar. All previous participants, as well as new investigators/centers that have shown interest in participating throughout the world will be invited.University of Pittsburgh will be responsible for collecting all required regulatory documents from other sites. Developing templates for questionnaires and other data collection forms. Will train approved sites on procedures. The coordinating center will be the recipient of de-identified data and will not be involved in the collection of data. Note that copies of training records, licenses, certificates should be maintained in the study regulatory binder and are subject to audit by the Research Conduct and Compliance Office (RCCO).
Interventions
OTHERQuestionnaire
Questionnaires
Sponsors
University of Pittsburgh
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. The diagnosis of AP based upon presence of two out of the three following criteria: 1. Abdominal pain typical to AP 2. Serum amylase or lipase levels more than three times the upper limit of normal 3. Imaging findings suggestive of AP 2. Willingness to participate in the study and ability to sign informed consent by patient or his/her proxy (if unable to speak).
Exclusion criteria
1. Age under 18 years 2. Unwilling to provide consent by patient or his/her proxy 3. Presence of pancreatic cancer 4. Presence of chronic pancreatitis 5. Occurrence of AP following a multiple trauma episode 6. Having history of organ transplant 7. Presence of any cancer which required chemotherapy or radiation therapy in the past year.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients with pancreatic necrosis as assessed by their clinical course. | 12 months | Evaluation of the existing risks, predictive scores, and markers of severe disease. |
| Number of patients with persistent organ failure as assessed by their clinical course. | 12 months | Evaluation of the current management and outcomes of acute pancreatitis around the world. |
Countries
United States
Outcome results
None listed